Biogen (BIIB) Cost of Revenue & History | Stock Alarm

Demo Sign up Log In

Biogen · Cost of Revenue

BIIB Cost of Revenue

Latest reported$3.21Bperiod endingJun 30, 2026

BIIB Cost of Revenue ($4.50M → $3.21B)

Annual cost of revenue

High-resolution chart · PNG

BIIB cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Cost of Revenue — Annual fiscal periods (USD)
Period ending	Cost of Revenue (USD)
Dec 31, 2025	2,897,000,000
Dec 31, 2024	2,310,400,000
Dec 31, 2023	2,533,400,000
Dec 31, 2022	2,278,300,000
Dec 31, 2021	2,109,699,999
Dec 31, 2020	1,805,200,000
Dec 31, 2019	1,955,400,000
Dec 31, 2018	1,816,300,000
Dec 31, 2017	1,630,000,000
Dec 31, 2016	1,433,200,000
Dec 31, 2015	1,240,400,000
Dec 31, 2014	1,171,000,000
Dec 31, 2013	857,700,000
Dec 31, 2012	545,494,000
Dec 31, 2011	466,780,000
Dec 31, 2010	400,262,000
Dec 31, 2009	382,104,000
Dec 31, 2008	401,989,000
Dec 31, 2007	335,192,000
Dec 31, 2006	274,383,000
Dec 31, 2005	373,614,000
Dec 31, 2004	554,319,000
Dec 31, 2003	284,739,000
Dec 31, 2002	1,457,000
Dec 31, 2001	136,510,000
Dec 31, 2000	125,198,000
Dec 31, 1999	111,005,000
Dec 31, 1998	74,509,000
Dec 31, 1997	50,188,000
Dec 31, 1996	28,525,000
Dec 31, 1995	10,504,000
Dec 31, 1994	9,948,000
Dec 31, 1993	5,500,000
Dec 31, 1992	2,200,000
Dec 31, 1991	43,300,000
Dec 31, 1990	35,400,000
Dec 31, 1989	25,200,000
Dec 31, 1988	21,100,000
Dec 31, 1987	21,000,000
Dec 31, 1986	23,300,000
Dec 31, 1985	4,500,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.